Pubmed    Pubmed Central
uBio Home | uBioRSS


 uBio  Web Results 1 - 10 of about 14

   Argentina sphyraena (Capelan de large) 
   Mallotus villosus (Capelan) 
   Trisopterus minutus (Capelan de france) 

   Gadus minutus 
   Mallotus villosus (Capon) 
   Phycis blennoides (Escolar) 
   Trisopterus minutus (poor cod) 

Broader Terms:
   Gadiformes (cods) 
   Gadus (common codfishes) 

More Specific:
   Capelan atlantique 
   Capelan france 
   Capelan large 
   Trisopterus minutus capelanus 
   Trisopterus minutus minutus 

Gadus minutus
NYPL Digital Gallery

External Resources:

Did you mean: Capellanus, capellan or capellanes?

1.  Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months.LinkIT
de Las Heras B, Saini KS, Boyle F, Ades F, de Azambuja E, Bozovic-Spasojevic I, Romano M, Capelan M, Prasad R, Pattu P, Massard C, Portera C, Saini ML, Singh BP, Venkitaraman R, McNally R, Leone M, Grande E, Gupta S
Oncology and therapy, 2020

2.  The prevalence of unmet needs in 625 women living beyond a diagnosis of early breast cancer.LinkIT
Capelan M, Battisti NML, McLoughlin A, Maidens V, Snuggs N, Slyk P, Peckitt C, Ring A
British journal of cancer, 2017

3.  Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?LinkIT
Capelan M, Roda D, Geuna E, Rihawi K, Bodla S, Kaye SB, Bhosle J, Banerji U, O'Brien M, de Bono JS, Popat S, Yap TA
Lung cancer (Amsterdam, Netherlands), 2017

4.  Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit.LinkIT
Papadatos-Pastos D, Roda D, De Miguel Luken MJ, Petruckevitch A, Jalil A, Capelan M, Michalarea V, Lima J, Diamantis N, Bhosle J, Molife LR, Banerji U, de Bono JS, Popat S, O'Brien MER, Yap TA
European journal of cancer (Oxford, England : 1990), 2017

5.  Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.LinkIT
Sanmamed MF, Esteban E, Uriol E, Zarate R, Capelan M, Muriel C, Crespo G, Berros JP, Pardo-Coto P, Perez Q, Alvarez-Fernández C, Jiménez Fonseca P, Luque M, Astudillo A
Journal of translational medicine, 2017

6.  Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population.LinkIT
Redana S, Sharp A, Lote H, Mohammed K, Papadimitraki E, Capelan M, Ring A
Breast (Edinburgh, Scotland), 2016

7.  Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer.LinkIT
Lote H, Sharp A, Redana S, Papadimitraki E, Capelan M, Ring A
Clinical oncology (Royal College of Radiologists (Great Britain)), 2016

8.  Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials.LinkIT
Geuna E, Roda D, Rafii S, Jimenez B, Capelan M, Rihawi K, Montemurro F, Yap TA, Kaye SB, De Bono JS, Molife LR, Banerji U
British journal of cancer, 2015

9.  Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials.LinkIT
Rafii S, Roda D, Geuna E, Jimenez B, Rihawi K, Capelan M, Yap TA, Molife LR, Kaye SB, de Bono JS, Banerji U
Clinical cancer research : an official journal of the American Association for Cancer Research, 2015

10.  Controversial issues in early-stage breast cancer: a global collaborative survey, supported by the European Society for Medical Oncology (ESMO).LinkIT
Zardavas D, Ades F, Spasojevic IB, Pugliano L, Capelan M, Paesmans M, de Azambuja E, Piccart M
Annals of oncology : official journal of the European Society for Medical Oncology, 2014